Prudential plc’s Royalty Pharma RPRX Stock Holding History

Prudential plc’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$593K	Hold	10,575	–	–	﹤0.01%	578
2026 Q1	$507K	Hold	10,575	–	–	﹤0.01%	567
2025 Q4	$409K	Sell	10,575 -171,153	-94%	-$6.53M	﹤0.01%	627
2025 Q3	$6.41M	Buy	181,728 +51,890	+40%	+$1.88M	0.05%	256
2025 Q2	$4.68M	Buy	129,838 +10,395	+9%	+$344K	0.03%	284
2025 Q1	$3.72M	Hold	119,443	–	–	0.02%	315
2024 Q4	$3.05M	Buy	119,443 +82,125	+220%	+$2.18M	0.02%	320
2024 Q3	$1.06M	Sell	37,318 -86,206	-70%	-$2.39M	0.01%	505
2024 Q2	$3.26M	Buy	+123,524	New	+$3.42M	0.02%	322
2024 Q1	–	Sell	-14,002	Closed	-$393K	–	861
2023 Q4	$393K	Sell	14,002 -50,708	-78%	-$1.39M	﹤0.01%	808
2023 Q3	$1.76M	Sell	64,710 -851	-1%	-$25.3K	0.02%	409
2023 Q2	$2.02M	Buy	+65,561	New	+$2.22M	0.02%	387

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prudential plc's RPRX Position: Q2 2026 in Review

Prudential plc held its Royalty Pharma (RPRX) position steady in Q2 2026 at 10,575 shares worth $593K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

Prudential plc first reported a position in RPRX in Q2 2023 and has held it in 12 quarters since. The position peaked at $6.41M in Q3 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Prudential plc held 10,575 shares of Royalty Pharma worth $593K as of Q2 2026.
Prudential plc left its Royalty Pharma share count unchanged in Q2 2026.
Royalty Pharma made up ﹤0.01% of Prudential plc's portfolio in Q2 2026, its #578 holding.
Prudential plc first reported a position in Royalty Pharma in Q2 2023 and has held it in 12 quarters since.
Prudential plc's Royalty Pharma position peaked at $6.41M in Q3 2025.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Prudential plc's 13F filing for Q2 2026, filed 14 Aug 2026.